Posts Tagged ‘venetoclax cost’

Adalimumab so far has been its showcase solution candidate, as it is furthest along in development and regulatory approval. Also already launched is Samsung Bioepis and Biogen’s Imraldi is also close to launch in their first markets, though Amgen’s Amgevita, which was the initially Humira biosimilar to get EMA approval is waiting in the wings…